-
PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study Hepatol. Int. (IF 6.6) Pub Date : 2024-04-16 Hongxiang Gao, Chenjie Xie, Jing Wang, Ji Ma, Shijian Liu, Li Xie, Yijie Zheng, Rui Dong, Shan Wang, Yongjun Fang, Yurui Wu, Xianwei Zhang, Xianying Lu, Yang Li, Weisong Li, Qiuhui Pan, Min Xu, Song Gu
-
MAFLD as part of systemic metabolic dysregulation Hepatol. Int. (IF 6.6) Pub Date : 2024-04-09 Jing Zhao, Lu Liu, Ying-Ying Cao, Xin Gao, Giovanni Targher, Christopher D. Byrne, Dan-Qin Sun, Ming-Hua Zheng
-
Efficacy and safety of precision-guided transjugular extrahepatic portosystemic shunt (TEPS) in the management of cavernous transformation of the portal vein with portal hypertension: a case series Hepatol. Int. (IF 6.6) Pub Date : 2024-04-09 Liu Zhang, Yi-Jiang Zhu, Xue-qing Wang, Rui-feng Wang, Li Dong, Liang Yin, Wei-Fu Lv, De-Lei Cheng, Chun-Ze Zhou
-
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure Hepatol. Int. (IF 6.6) Pub Date : 2024-04-05 Rakhi Maiwall, Satender Pal Singh, Paolo Angeli, Richard Moreau, Aleksander Krag, Virender Singh, Ashwani K. Singal, S. S. Tan, Puneet Puri, Mamun Mahtab, George Lau, Qin Ning, Manoj Kumar Sharma, P. N. Rao, Dharmesh Kapoor, Subhash Gupta, Ajay Duseja, Manav Wadhawan, Dinesh Jothimani, Sanjiv Saigal, Sunil Taneja, Akash Shukla, Pankaj Puri, Deepak Govil, Gaurav Pandey, Kaushal Madan, C. E. Eapen, Jaya
-
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments Hepatol. Int. (IF 6.6) Pub Date : 2024-04-02
Abstract Background Evidence has proven that liver fibrosis or even cirrhosis can be reversed by anti-HBV treatment. However, the difference of fibrosis regression rates in short-term and long-term antiviral therapy remain unclear. Therefore, we aimed to identify the dynamic changes in fibrosis regression rate in patients with three-time liver biopsies during 5 years antiviral therapy. Methods CHB
-
Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH) Hepatol. Int. (IF 6.6) Pub Date : 2024-03-27 Melek Büyük, Neslihan Berker, Doğu Vurallı Bakkaloğlu, İbrahim Volkan Şenkal, Zerrin Önal, Mine Güllüoğlu
-
Global burden and trends of acute viral hepatitis among children and adolescents from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019 Hepatol. Int. (IF 6.6) Pub Date : 2024-03-26 Wanglong Xiao, Jingwei Zhao, Yiwen Chen, Xingzhu Liu, Chang Xu, Jiaxu Zhang, Yongbing Qian, Qiang Xia
-
Prophylaxis of hepatic encephalopathy: current and future drug targets Hepatol. Int. (IF 6.6) Pub Date : 2024-03-16
Abstract Hepatic encephalopathy is described by a broad spectrum of neurological and psychiatric aberrations resulting due to advanced liver dysfunction. It is a neurological disorder due to hepatic insufficiency and/or portosystemic shunts. Its clinical presentation includes neuropsychiatric dysfunction ranging from subclinical changes to comatose state. It is a sign of poor prognosis in cirrhotics
-
Safety of right liver donation after improving steatosis through weight loss in living donors: a retrospective study Hepatol. Int. (IF 6.6) Pub Date : 2024-03-15 Young-In Yoon, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park
-
Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies Hepatol. Int. (IF 6.6) Pub Date : 2024-03-14 Wen Chen, Xiaodan Lin, Zhenheng Wu, Wei Pan, Qiming Ke, Yanling Chen
-
“Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury Hepatol. Int. (IF 6.6) Pub Date : 2024-03-13 Pedro David Wendel-Garcia, Rea Andermatt, Christian Bode, Sascha David, Klaus Stahl
-
Surgical risk stratification in patients with cirrhosis Hepatol. Int. (IF 6.6) Pub Date : 2024-03-12 Ana Ostojic, Nadim Mahmud, K. Rajender Reddy
-
Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis Hepatol. Int. (IF 6.6) Pub Date : 2024-03-09 Shaowen Jiang, Simin Guo, Yan Huang, Yalin Yin, Jingwen Feng, Huijuan Zhou, Qing Guo, Weijing Wang, Haiguang Xin, Qing Xie
-
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections Hepatol. Int. (IF 6.6) Pub Date : 2024-03-09 Tao Chen, Guang Chen, Guiqiang Wang, Sombat Treeprasertsuk, Cosmas Rinaldi Adithya Lesmana, Han-Chieh Lin, Mamun Al-mahtab, Yogesh K. Chawla, Soek-Siam Tan, Jia-Horng Kao, Man-Fung Yuen, Guan-Huei Lee, Diana Alcantara-Payawal, Nobuaki Nakayama, Zaigham Abbas, Wasim Jafri, Dong-Joon Kim, Ashok Choudhury, Rakhi Mahiwall, Jinlin Hou, Saeed Hamid, Jidong Jia, J. S. Bajaj, Fusheng Wang, Shiv K. Sarin, Qin
-
-
Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases Hepatol. Int. (IF 6.6) Pub Date : 2024-03-01 Ming Liu, Quan Bao, Tingting Zhao, Longfei Huang, Danhua Zhang, Yanyan Wang, Xiaoluan Yan, Hongwei Wang, Kemin Jin, Wei Liu, Kun Wang, Baocai Xing
-
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation Hepatol. Int. (IF 6.6) Pub Date : 2024-02-28 Dong-Sik Kim, Young-In Yoon, Beom Kyung Kim, Ashok Choudhury, Anand Kulkarni, Jun Yong Park, Jongman Kim, Dong Hyun Sinn, Dong Jin Joo, YoungRok Choi, Jeong-Hoon Lee, Ho Joong Choi, Ki Tae Yoon, Sun Young Yim, Cheon-Soo Park, Deok-Gie Kim, Hae Won Lee, Won-Mook Choi, Young Eun Chon, Woo-Hyoung Kang, Jinsoo Rhu, Jae Geun Lee, Yuri Cho, Pil Soo Sung, Han Ah Lee, Ji Hoon Kim, Si Hyun Bae, Jin Mo Yang
-
Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population Hepatol. Int. (IF 6.6) Pub Date : 2024-02-26 Yurou Xu, Youyi Wang, Qi Zhao, Bo Chen, Na Wang, Tiejun Zhang, Yonggen Jiang, Yiling Wu, Na He, Genming Zhao, Xing Liu
-
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update Hepatol. Int. (IF 6.6) Pub Date : 2024-02-24 Yimin Mao, Shiwu Ma, Chenghai Liu, Xiaoyan Liu, Minghua Su, Dongliang Li, Yiling Li, Gongying Chen, Jun Chen, Jinjun Chen, Jingmin Zhao, Xiaoyan Guo, Jieting Tang, Yuzheng Zhuge, Qing Xie, Wen Xie, Rongtao Lai, Dachuan Cai, Qingxian Cai, Yang Zhi, Xiaoyun Li
-
Artificial intelligence in liver imaging: methods and applications Hepatol. Int. (IF 6.6) Pub Date : 2024-02-20 Peng Zhang, Chaofei Gao, Yifei Huang, Xiangyi Chen, Zhuoshi Pan, Lan Wang, Di Dong, Shao Li, Xiaolong Qi
-
Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan Hepatol. Int. (IF 6.6) Pub Date : 2024-02-20 Chao-Wei Hsu, Shin-Cheh Chen, Po-Nan Wang, Hung-Ming Wang, Yi-Cheng Chen, Chau-Ting Yeh
-
Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B Hepatol. Int. (IF 6.6) Pub Date : 2024-02-20 Min Zhang, Jing Li, Zhiqiang Xu, Peiyao Fan, Yi Dong, Fuchuan Wang, Yinjie Gao, Jianguo Yan, Lili Cao, Dong Ji, Danni Feng, Yanwei Zhong, Yang Zhang, Weiguo Hong, Chao Zhang, Fu-Sheng Wang
-
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis Hepatol. Int. (IF 6.6) Pub Date : 2024-02-08 Aikaterini Kamiliou, Vasileios Lekakis, Lampros Chrysavgis, Evangelos Cholongitas
-
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence Hepatol. Int. (IF 6.6) Pub Date : 2024-02-08 Benedikt Simbrunner, Benedikt S. Hofer, Philipp Schwabl, Kerstin Zinober, Oleksandr Petrenko, Claudia Fuchs, Georg Semmler, Rodrig Marculescu, Mattias Mandorfer, Christian Datz, Michael Trauner, Thomas Reiberger
-
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes Hepatol. Int. (IF 6.6) Pub Date : 2024-01-22 Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li
-
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan Hepatol. Int. (IF 6.6) Pub Date : 2024-01-21 Ming-Lung Yu, Chi‐Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Chung-Feng Huang, Kuo-Chih Tseng, Ching-Chu Lo, Ming-Jong Bair, Szu-Jen Wang, Jee-Fu Huang, Ming-Lun Yeh, Chun-Ting Chen, Ming-Chang Tsai, Chien-Wei Huang, Pei-Lun Lee, Tzeng-Hue Yang, Yi-Hsiang Huang, Lee-Won Chong, Chien-Lin Chen, Chi-Chieh Yang, Chao-Hung Hung, Sheng‐Shun Yang, Pin-Nan Cheng, Tsai-Yuan Hsieh, Jui-Ting Hu, Wen-Chih Wu, Chien-Yu
-
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease Hepatol. Int. (IF 6.6) Pub Date : 2024-01-16 Shao-Wen Wang, Tsung-Han Hsieh, Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
-
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma Hepatol. Int. (IF 6.6) Pub Date : 2024-01-12 Hyung-Don Kim, Young-Gyu Park, Sejin Kim, Kyu-Pyo Kim, Sook-Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Changhoon Yoo
-
FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease Hepatol. Int. (IF 6.6) Pub Date : 2024-01-06 Lin Li, Lina Kong, Shuai Xu, Changyuan Wang, Jiangning Gu, Haifeng Luo, Qiang Meng
-
The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease Hepatol. Int. (IF 6.6) Pub Date : 2024-01-06 Haifeng Wu, Meng Zhou, Qin Jin, Xun Wang, Yue Xu, Ming Li, Shuhui Chen, Qin Tang, Qi Wang, Baoying Hu, Hongpei Wu, Mingbing Xiao, Lishuai Qu, Qiong Zhang, Jinxia Liu
-
Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation Hepatol. Int. (IF 6.6) Pub Date : 2024-01-03 Shu Feng, Xingming Xie, Jianchao Li, Xu Xu, Chaochun Chen, Gaoliang Zou, Guoyuan Lin, Tao Huang, Ruihan Hu, Tao Ran, Lu Han, Qingxiu Zhang, Yuanqingxiao Li, Xueke Zhao
-
Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis Hepatol. Int. (IF 6.6) Pub Date : 2024-01-02 Jian-Xing Luo, Yang Zhang, Xiao-Yu Hu, Ne Xiang
-
Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma Hepatol. Int. (IF 6.6) Pub Date : 2023-12-30 Cheng-Lei Yang, Rui Song, Jun-Wen Hu, Jun-Tao Huang, Nan-Nan Li, Hang-Hang Ni, Yuan-Kuan Li, Jie Zhang, Zhan Lu, Min Zhou, Jun-Duo Wang, Min-Jun Li, Guo-Hua Zhan, Tao Peng, Hong-Ping Yu, Lu-Nan Qi, Qiu-Yan Wang, Bang-De Xiang
-
Breaking new ground: MASLD vs. MAFLD—which holds the key for risk stratification? Hepatol. Int. (IF 6.6) Pub Date : 2023-12-21
Abstract Background The classification and nomenclature of non-alcoholic fatty liver disease (NAFLD) has been the subject of ongoing debate in the medical community. Through the introduction of metabolic dysfunction-associated fatty liver disease (MAFLD) and the later release of metabolic dysfunction-associated steatotic liver disease (MASLD), the limitations associated with NAFLD are intended to be
-
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study Hepatol. Int. (IF 6.6) Pub Date : 2023-12-11 Daniel Q. Huang, Sally Tran, Scott Barnett, Biyao Zou, Yee Hui Yeo, Ramsey Cheung, Mindie H. Nguyen
-
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors Hepatol. Int. (IF 6.6) Pub Date : 2023-12-01 Zhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, Yi-Nan Li, Yang-Kai Fu, Zhi-Bo Zhang, De-Yi Liu, Han Li, Xiang-Ye Ou, Shao-Wu Zhuang, Mao-Lin Yan
-
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age–period–cohort model for estimating demand from antecedent anti-HCV survey Hepatol. Int. (IF 6.6) Pub Date : 2023-11-21 Ting-Yu Lin, Hsiao-Hsuan Jen, Tsung-Hui Hu, Yu-Chin Yao, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Yen-Po Yeh
-
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer Hepatol. Int. (IF 6.6) Pub Date : 2023-11-18 Ao Huang, De-Zhen Guo, Xuan Zhang, Ying Sun, Shi-Yu Zhang, Xin Zhang, Xiu-Tao Fu, Yu-Peng Wang, Guo-Huan Yang, Qi-Man Sun, Yi-Feng He, Kang Song, Xiao-Wu Huang, Xin-Rong Yang, Wei-Ren Liu, Zhen-Bin Ding, Ying-Hong Shi, Jia Fan, Jian Zhou
-
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway Hepatol. Int. (IF 6.6) Pub Date : 2023-11-20 Fu Wang, Wei-Qi Xu, Wan-Qin Zhang, Ru-Chen Xu, Jia-Lei Sun, Guang-Cong Zhang, Zhi-Yong Liu, Zhuo-Ran Qi, Ling Dong, Shu-Qiang Weng, Xi-Zhong Shen, Tao-Tao Liu, Ying Fang, Ji-Min Zhu
-
Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies Hepatol. Int. (IF 6.6) Pub Date : 2023-11-13 Mi Tang, Liling Xiong, Jianghui Cai, Jinzhu Fu, Hong Liu, Ying Ye, Li Yang, ShaSha Xing, Xiao Yang
-
Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis Hepatol. Int. (IF 6.6) Pub Date : 2023-11-11 Lanlan Chen, Yuexuan Zhao, Mingyue Li, Guoyue Lv
-
Autophagy and extracellular vesicles in the liver endothelium: friends or foes? Hepatol. Int. (IF 6.6) Pub Date : 2023-11-09 Louise Biquard, Pierre-Emmanuel Rautou
-
Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated. Hepatol. Int. (IF 6.6) Pub Date : 2023-11-09 Sai Li,Yong Li
-
Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high? Hepatol. Int. (IF 6.6) Pub Date : 2023-10-31 Fu-Sheng Wang, Jing Li, Chao Zhang
-
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma Hepatol. Int. (IF 6.6) Pub Date : 2023-10-25 Shi-Chuan Tang, Kai-Ling Zhang, Kong-Ying Lin, Yi-Dan Tang, Jun Fu, Wei-Ping Zhou, Jian-Xi Zhang, Jie Kong, Xiao-Lu He, Zheng-Hong Sun, Cong Luo, Hong-Zhi Liu, Yong-Ping Lai, Yong-Yi Zeng
-
Targeting ferroptosis in hepatocellular carcinoma Hepatol. Int. (IF 6.6) Pub Date : 2023-10-26 Yuqian Mo, Zhilin Zou, Erbao Chen
-
Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease Hepatol. Int. (IF 6.6) Pub Date : 2023-10-21 Itsuo Nagayama, Kenya Kamimura, Takashi Owaki, Masayoshi Ko, Takuro Nagoya, Yuto Tanaka, Marina Ohkoshi, Toru Setsu, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Shuji Terai
-
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma Hepatol. Int. (IF 6.6) Pub Date : 2023-10-21 Hiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, Takahiko Sakaue, Yasuko Imamura, Atsutaka Masuda, Toru Nakamura, Hironori Koga, Yujin Hoshida, Takumi Kawaguchi
-
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations Hepatol. Int. (IF 6.6) Pub Date : 2023-10-21 Ming Zhao, Zhi Guo, Ying-Hua Zou, Xiao Li, Zhi-Ping Yan, Min-Shan Chen, Wei-Jun Fan, Hai-Liang Li, Ji-Jin Yang, Xiao-Ming Chen, Lin-Feng Xu, Yue-Wei Zhang, Kang-Shun Zhu, Jun-Hui Sun, Jia-Ping Li, Yong Jin, Hai-Peng Yu, Feng Duan, Bin Xiong, Guo-Wen Yin, Hai-Lan Lin, Yi-Long Ma, Hua-Ming Wang, Shan-Zhi Gu, Tong-Guo Si, Xiao-Dong Wang, Chang Zhao, Wen-Chang Yu, Jian-Hai Guo, Jian Zhai, Yong-Hui Huang
-
Gender differences in non-alcoholic fatty liver disease in obese children and adolescents: a large cross-sectional study Hepatol. Int. (IF 6.6) Pub Date : 2023-10-20 Binghan Jin, Zhaoyuan Wu, Shan Wang, Zhu Yu, Rahim Ullah, Xinyi Liang, Wei Wu, Ke Huang, Yan Ni, Jianbing Wang, Guanping Dong, Junfen Fu
-
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis Hepatol. Int. (IF 6.6) Pub Date : 2023-10-16 Jiaxi Liu, Peng Wang, Liqi Shang, Zhoubo Zhang, Yulong Tian, Xiaowei Chen, Yanan Ma, Haibo Shao
-
New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32 Hepatol. Int. (IF 6.6) Pub Date : 2023-10-13 Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Seong Hee Kang, Young Chang, Jeong-Ju Yoo, Baek Gyu Jun, Sung Won Lee, Jung Gil Park, Ji Won Park, Sung-Eun Kim, Tae Yeob Kim, Soung Won Jeong, Ki Tae Suk, Moon Young Kim, Sang Gyune Kim, Won Kim, Jae Young Jang, Jin Mo Yang, Dong Joon Kim
-
Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity Hepatol. Int. (IF 6.6) Pub Date : 2023-10-12 Xue Cheng, Wei Wang, Ziyao Zhang, Haoquan Zhang, Peng Zhu, Ran He, Mi Wu, Ting Zhou, Ying Jiang, Lang Jiang, Yiqing Chen, Zhihui Liang, Xiongwen Wu, Xiufang Weng
-
Outcomes of living donor liver transplantation for patients with APASL defined-acute-on-chronic liver failure. Hepatol. Int. (IF 6.6) Pub Date : 2023-10-09 Shweta A Singh,Richa Bhargava,Subhash Gupta
-
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection Hepatol. Int. (IF 6.6) Pub Date : 2023-10-03 Anika Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa-Breier, Janina Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer
-
Is laparoscopic liver resection more suitable for diabetic patients with hepatocellular carcinoma? The debate continues. Hepatol. Int. (IF 6.6) Pub Date : 2023-10-01 Shiye Yang,Chunqiu Xia
-
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding Hepatol. Int. (IF 6.6) Pub Date : 2023-09-29 Zhiying He, Bingqiong Wang, Xiaoning Wu, Zhongjie Hu, Chunqing Zhang, Yanqin Hao, Yongfeng Yang, Yan Huang, Wei Rao, Jing Wang, Jialing Zhou, Shuai Xia, Xiaojuan Ou, Jidong Jia, Hong You
-
How non-alcoholic fatty liver disease and cirrhosis affect the heart Hepatol. Int. (IF 6.6) Pub Date : 2023-09-28 Søren Møller, Signe Wiese, Mads Barløse, Jens D. Hove
-
Lymphatic drainage dysfunction is related to clinically significant portal hypertension Hepatol. Int. (IF 6.6) Pub Date : 2023-09-24 Ruixue Ma, Yasuko Iwakiri
-
Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study Hepatol. Int. (IF 6.6) Pub Date : 2023-09-25 Chin-I. Shih, Kuan-Ta Wu, Meng-Hsuan Hsieh, Jeng-Fu Yang, Yi-Yu Chen, Wei-Lun Tsai, Wen-Chi Chen, Po-Cheng Liang, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Ming-Yen Hsieh, Yi-Hung Lin, Tyng-Yuan Jang, Chih-Wen Wang, Ming-Lun Yeh, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Chi-Kung Ho, Wan-Long Chuang, Ming-Lung Yu